GI High Risk Cancer Program
Stanford’s GI High Risk Cancer Program is dedicated to gastrointestinal cancer prevention and counseling. Our mission is to serve patients and families with hereditary cancer syndromes, patients with high cancer risk due to non-genetic factors, as well as persons at any level of colorectal cancer risk.
Our Molecular Imaging program is actively funded by NIH to identify novel biomarkers for early detection of cancer. Our physicians are involved in pioneering research that advances early detection of and treatment of gastrointestinal cancers.
In the event that GI cancer is detected, our physicians work closely with Stanford’s world class Cancer Center to develop a treatment plan based on cutting edge research and technology.
The following is a list of services that we offer:
- Risk assessment, genetic counseling, genetic testing (Lynch syndrome, familial adenomatous polyposis, hereditary gastric cancer, hereditary pancreatitis, and other genetic syndromes)
- Colorectal cancer screening and surveillance for average and high risk persons, with emphasis on quality indicators per national guidelines
- Surveillance in persons at risk for gastric, pancreatic and other gastrointestinal cancers
- Management of Barrett’s esophagus
- Screening for hepatocellular carcinoma
- Surveillance for colorectal dysplasia and cancer in patients with inflammatory bowel disease
Featured Video
Uri Ladabaum, MD, discusses the risk factors, symptoms, and treatment options for colorectal cancer, and the importance of getting screened for the disease.








